These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

610 related articles for article (PubMed ID: 29565037)

  • 1. Circular noncoding RNAs as potential therapies and circulating biomarkers for cardiovascular diseases.
    Bayoumi AS; Aonuma T; Teoh JP; Tang YL; Kim IM
    Acta Pharmacol Sin; 2018 Jul; 39(7):1100-1109. PubMed ID: 29565037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long noncoding RNA/circular noncoding RNA-miRNA-mRNA axes in cardiovascular diseases.
    Li M; Duan L; Li Y; Liu B
    Life Sci; 2019 Sep; 233():116440. PubMed ID: 31047893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Significance of MicroRNAs, Long Non-Coding RNAs, and CircRNAs in Cardiovascular Diseases.
    Singh DD; Kim Y; Choi SA; Han I; Yadav DK
    Cells; 2023 Jun; 12(12):. PubMed ID: 37371099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circular RNAs as Potential Theranostics in the Cardiovascular System.
    Bei Y; Yang T; Wang L; Holvoet P; Das S; Sluijter JPG; Monteiro MC; Liu Y; Zhou Q; Xiao J
    Mol Ther Nucleic Acids; 2018 Dec; 13():407-418. PubMed ID: 30368217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Guide to the Short, Long and Circular RNAs in Hypertension and Cardiovascular Disease.
    Prestes PR; Maier MC; Woods BA; Charchar FJ
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32455975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The circulating non-coding RNA landscape for biomarker research: lessons and prospects from cardiovascular diseases.
    E S; Costa MC; Kurc S; Drożdż A; Cortez-Dias N; Enguita FJ
    Acta Pharmacol Sin; 2018 Jul; 39(7):1085-1099. PubMed ID: 29877319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circular RNAs as a Diagnostic and Therapeutic Target in Cardiovascular Diseases.
    Joaquim VHA; Pereira NP; Fernandes T; Oliveira EM
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circular RNAs as Novel Biomarkers for Cardiovascular Diseases.
    Zhou Q; Zhang Z; Bei Y; Li G; Wang T
    Adv Exp Med Biol; 2018; 1087():159-170. PubMed ID: 30259365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating MicroRNA and Long Noncoding RNA as Biomarkers of Cardiovascular Diseases.
    Shi Q; Yang X
    J Cell Physiol; 2016 Apr; 231(4):751-5. PubMed ID: 26308238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circular RNAs: Biogenesis, Biological Functions, and Roles in Myocardial Infarction.
    Li J; Han Y; Wang S; Wu X; Cao J; Sun T
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Circular RNAs in the Pathogenesis of Cardiovascular Disease.
    Li B; Li Y; Hu L; Liu Y; Zhou Q; Wang M; An Y; Li P
    J Cardiovasc Transl Res; 2020 Aug; 13(4):572-583. PubMed ID: 32399680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A narrative review of circular RNAs as potential biomarkers and therapeutic targets for cardiovascular diseases.
    Liu C; Li N; Dai G; Cavdar O; Fang H
    Ann Transl Med; 2021 Apr; 9(7):578. PubMed ID: 33987276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Which long noncoding RNAs and circular RNAs contribute to inflammatory bowel disease?
    Lin L; Zhou G; Chen P; Wang Y; Han J; Chen M; He Y; Zhang S
    Cell Death Dis; 2020 Jun; 11(6):456. PubMed ID: 32541691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential diagnostic and therapeutic value of circular RNAs in cardiovascular diseases.
    Sun JY; Shi Y; Cai XY; Liu J
    Cell Signal; 2020 Jul; 71():109604. PubMed ID: 32201331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Landscape of Noncoding RNA in Pulmonary Hypertension.
    Deng L; Han X; Wang Z; Nie X; Bian J
    Biomolecules; 2022 Jun; 12(6):. PubMed ID: 35740920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noncoding RNAs as Key Regulators for Cardiac Development and Cardiovascular Diseases.
    Kawaguchi S; Moukette B; Hayasaka T; Haskell AK; Mah J; Sepúlveda MN; Tang Y; Kim IM
    J Cardiovasc Dev Dis; 2023 Apr; 10(4):. PubMed ID: 37103045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circular RNAs as novel regulators, biomarkers and potential therapies in fibrosis.
    Jiang X; Ning Q
    Epigenomics; 2019 Jul; 11(9):1107-1116. PubMed ID: 31240943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insights into circular RNAs: Biogenesis, function and their regulatory roles in cardiovascular disease.
    Ding C; Zhou Y
    J Cell Mol Med; 2023 May; 27(10):1299-1314. PubMed ID: 37002786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating Noncoding RNAs as Biomarkers of Cardiovascular Disease and Injury.
    Viereck J; Thum T
    Circ Res; 2017 Jan; 120(2):381-399. PubMed ID: 28104771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathological Bases and Clinical Application of Long Noncoding RNAs in Cardiovascular Diseases.
    Zhang C; Niu K; Lian P; Hu Y; Shuai Z; Gao S; Ge S; Xu T; Xiao Q; Chen Z
    Hypertension; 2021 Jul; 78(1):16-29. PubMed ID: 34058852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.